Think Research Corp (TSXV:THNK)
C$ 0.315 0 (0%) Market Cap: 24.82 Mil Enterprise Value: 71.97 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

Q3 2022 Think Research Corporation Earnings Call Transcript

Nov 28, 2022 / 02:00PM GMT
Release Date Price: C$0.32 (-8.57%)
Operator

Good morning, ladies and gentlemen, and welcome to the Think Research Corporation third-quarter 2022 financial results conference call. (Operator Instructions) I would now like to turn the conference over to Mr. Sachin Aggarwal, CEO. Please go ahead.

Sachin Aggarwal
Think Research Corporation - CEO

Thank you, operator, and good day to everyone who's joining us this morning. Also joining me on the call today is our CFO, John Hayes, who is going to review the financial results in more detail after I discuss some operational achievements during the third quarter and the first nine months of fiscal 2022, which continues to produce record revenue results despite some seasonal slowdowns that typically occur in our clinics and in our clinical education segment during the summer months.

Now, before I go into our operational results, I just want to briefly review who we are and what we're trying to accomplish. Think Research is an industry leader in delivering knowledge-based digital health software solutions. Our evidence-based healthcare technology solutions

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot